Education
About Us
Working with TipRanks
Follow Us
Quantum-Si Incorporated (QSI)
:QSI
QSI Stock Chart & Stats
$1.84
-$0.96(-27.61%)
At close: 4:00 PM EST
$1.84
-$0.96(-27.61%)
Day’s Range― - ―
52-Week Range$0.95 - $5.77
Previous CloseN/A
Volume35.47M
Average Volume (3M)15.52M
Market Cap
$339.40M
Enterprise Value$73.51M
Total Cash (Recent Filing)$225.84M
Total Debt (Recent Filing)$4.61M
Price to Earnings (P/E)―
Beta2.67
Next Earnings
Mar 09, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding195,552,170
10 Day Avg. Volume8,380,659
30 Day Avg. Volume15,519,586
Financial Highlights & Ratios
PEG Ratio-0.87
Price to Book (P/B)1.79
Price to Sales (P/S)126.43
P/FCF Ratio-4.19
Enterprise Value/Market Cap0.22
Enterprise Value/Revenue23.14
Enterprise Value/Gross Profit44.80
Enterprise Value/Ebitda-0.65
Forecast
1Y Price Target
$2.25Price Target Upside22.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Investor InterestAnalyst recommends buying QSI stock ahead of the Analyst and Investor Day, as the launch of Proteus could be a major catalyst for the stock.
Market ExpansionProteus is expected to penetrate broader markets than Platinum/Platinum Pro with a price range 3-5x higher than the current Platinum system but still below mass spectrometry systems priced over $1M.
Platform ImprovementsNew data reflects platform improvements, demonstrating materially improved performance, including significantly more alignments per well, longer reads, and higher signal-to-noise ratio.
Bears Say
Commercialization ChallengesManagement noted persistent headwinds in commercialization of Platinum as a result of funding cuts at the NIH.
Sales ImpactQSI's Platinum instrument sales were modestly lower than expectations and impacted by National Institutes of Health (NIH) funding uncertainty.
Unclear DemandAlthough the company appears positioned to become 'the proteomics lab of the future,' demand for and applications of protein sequencing currently remain relatively unclear.
Quantum-Si News
QSI FAQ
What was Quantum-Si Incorporated’s price range in the past 12 months?
Quantum-Si Incorporated lowest stock price was $0.95 and its highest was $5.77 in the past 12 months.
What is Quantum-Si Incorporated’s market cap?
Quantum-Si Incorporated’s market cap is $339.40M.
When is Quantum-Si Incorporated’s upcoming earnings report date?
Quantum-Si Incorporated’s upcoming earnings report date is Mar 09, 2026 which is in 84 days.
How were Quantum-Si Incorporated’s earnings last quarter?
Quantum-Si Incorporated released its earnings results on Nov 05, 2025. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of -$0.133 by -$0.037.
Is Quantum-Si Incorporated overvalued?
According to Wall Street analysts Quantum-Si Incorporated’s price is currently Undervalued.
Does Quantum-Si Incorporated pay dividends?
Quantum-Si Incorporated does not currently pay dividends.
What is Quantum-Si Incorporated’s EPS estimate?
Quantum-Si Incorporated’s EPS estimate is -0.12.
How many shares outstanding does Quantum-Si Incorporated have?
Quantum-Si Incorporated has 195,552,170 shares outstanding.
What happened to Quantum-Si Incorporated’s price movement after its last earnings report?
Quantum-Si Incorporated reported an EPS of -$0.17 in its last earnings report, missing expectations of -$0.133. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of Quantum-Si Incorporated?
Currently, no hedge funds are holding shares in QSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Quantum-Si Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.25 (22.28% Upside)
$2.25 (22.28% Upside)
Blogger Sentiment
Neutral
QSI Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 752.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $159.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 4.7%
Last 30 Days ▼ 4.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
74.22%
12-Months-Change
Fundamentals
Return on Equity
-52.44%
Trailing 12-Months
Asset Growth
10.01%
Trailing 12-Months
Company Description
Quantum-Si Incorporated
Quantum-Si (QSI) is a biotechnology company focused on advancing the field of proteomics through its proprietary next-generation protein sequencing technology. Operating primarily in the life sciences sector, Quantum-Si aims to unlock the potential of proteins to drive discoveries in drug development, diagnostics, and personalized medicine. The company's core product offerings include its protein sequencing platform and related software solutions, which enable researchers and clinicians to analyze protein structures and functions with unprecedented accuracy and speed.
QSI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call highlighted significant advancements in product development and strategic placements in academic institutions, despite financial challenges due to market conditions and a costly lease termination. The focus on innovation and cost management was balanced against the impact of external funding uncertainties.View all QSI earnings summariesQSI Stock 12 Month Forecast
Average Price Target
$2.25
▲(22.28% Upside)
Technical Analysis
Ownership Overview
21.57% Insiders
6.69% Mutual Funds
10.51% Other Institutional Investors
49.65% Public Companies and Individual Investors